Sarepta Therapeutics (SRPT) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.83% |
| Dec 31, 2025 | 2.33% |
| Sep 30, 2025 | 4.67% |
| Jun 30, 2025 | 5.00% |
| Mar 31, 2025 | 3.29% |
| Dec 31, 2024 | 16.80% |
| Sep 30, 2024 | 16.16% |
| Jun 30, 2024 | 14.40% |
| Mar 31, 2024 | 10.42% |
| Dec 31, 2023 | 14.73% |
| Sep 30, 2023 | 21.33% |
| Jun 30, 2023 | 20.17% |
| Mar 31, 2023 | 18.67% |
| Dec 31, 2022 | 19.05% |
| Sep 30, 2022 | 31.58% |
| Jun 30, 2022 | 46.10% |
| Mar 31, 2022 | 42.98% |
| Dec 31, 2021 | 49.32% |
| Sep 30, 2021 | 40.44% |
| Jun 30, 2021 | 68.34% |
| Mar 31, 2021 | 66.93% |
| Dec 31, 2020 | 61.25% |
| Sep 30, 2020 | 71.99% |
| Jun 30, 2020 | 65.57% |
| Mar 31, 2020 | 64.77% |
| Dec 31, 2019 | 43.94% |
| Sep 30, 2019 | 39.78% |
| Jun 30, 2019 | 38.96% |
| Mar 31, 2019 | 48.13% |
| Dec 31, 2018 | 41.30% |
| Sep 30, 2018 | 31.18% |
| Jun 30, 2018 | 46.69% |
| Mar 31, 2018 | 46.40% |
| Dec 31, 2017 | 44.87% |
| Mar 31, 2017 | 61.44% |
| Dec 31, 2016 | 50.81% |
| Sep 30, 2016 | 51.49% |
| Jun 30, 2016 | 22.19% |
| Dec 31, 2015 | 42.88% |